Onconetix announces financing through private placement, debt settlement

Onconetix (ONCO) announced the September 22, 2025 signing and closing of a private placement of shares of the Company’s Series D Convertible Preferred Stock, 0.00001 par value per share, for an aggregate purchase price of approximately 9.3 million was paid in cash and the balance was used to offset certain amounts owed by the Company to certain investors. The Ser ...